213 related articles for article (PubMed ID: 1898351)
1. Differential rates of conversion of rat proinsulins I and II. Evidence for slow cleavage at the B-chain/C-peptide junction of proinsulin II.
Sizonenko SV; Halban PA
Biochem J; 1991 Sep; 278 ( Pt 3)(Pt 3):621-5. PubMed ID: 1898351
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of proinsulin conversion in human islets.
Sizonenko S; Irminger JC; Buhler L; Deng S; Morel P; Halban PA
Diabetes; 1993 Jun; 42(6):933-6. PubMed ID: 8495816
[TBL] [Abstract][Full Text] [Related]
3. Processing of proinsulin by furin, PC2, and PC3 in (co) transfected COS (monkey kidney) cells.
Vollenweider F; Kaufmann J; Irminger JC; Halban PA
Diabetes; 1995 Sep; 44(9):1075-80. PubMed ID: 7657031
[TBL] [Abstract][Full Text] [Related]
4. The intracellular handling of insulin-related peptides in isolated pancreatic islets. Evidence for differential rates of degradation of insulin and C-peptide.
Rhodes CJ; Halban PA
Biochem J; 1988 Apr; 251(1):23-30. PubMed ID: 3291861
[TBL] [Abstract][Full Text] [Related]
5. Slow cleavage at the proinsulin B-chain/connecting peptide junction associated with low levels of endoprotease PC1/3 in transformed beta cells.
Neerman-Arbez M; Sizonenko SV; Halban PA
J Biol Chem; 1993 Aug; 268(22):16098-100. PubMed ID: 8393853
[TBL] [Abstract][Full Text] [Related]
6. Reversed-phase high-performance liquid chromatographic analyses of insulin biosynthesis in isolated rat and mouse islets.
Linde S; Nielsen JH; Hansen B; Welinder BS
J Chromatogr; 1989 Jan; 462():243-54. PubMed ID: 2661585
[TBL] [Abstract][Full Text] [Related]
7. Analysis of proinsulin and its conversion products by reversed-phase high-performance liquid chromatography.
Linde S; Welinder BS; Nielsen JH
J Chromatogr; 1993 May; 614(2):185-204. PubMed ID: 8314931
[TBL] [Abstract][Full Text] [Related]
8. Insulin biosynthesis in the rat: demonstration of two proinsulins.
Clark JL; Steiner DF
Proc Natl Acad Sci U S A; 1969 Jan; 62(1):278-85. PubMed ID: 4890253
[TBL] [Abstract][Full Text] [Related]
9. Proinsulin and its conversion intermediates in human pancreas and isolated islet tissue: kinetics and steady-state analysis.
Hou X; Ling Z; Zambre Y; Foriers A; Houssa P; Deberg M; Sodoyez JC; Hales CN; Van der Auwera BJ; Pipeleers D; Van Schravendijk C
Pancreas; 1997 Aug; 15(2):113-21. PubMed ID: 9260195
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and clinical implications of proinsulin conversion intermediates.
Given BD; Cohen RM; Shoelson SE; Frank BH; Rubenstein AH; Tager HS
J Clin Invest; 1985 Oct; 76(4):1398-405. PubMed ID: 3902891
[TBL] [Abstract][Full Text] [Related]
11. Incomplete processing of proinsulin to insulin accompanied by elevation of Des-31,32 proinsulin intermediates in islets of mice lacking active PC2.
Furuta M; Carroll R; Martin S; Swift HH; Ravazzola M; Orci L; Steiner DF
J Biol Chem; 1998 Feb; 273(6):3431-7. PubMed ID: 9452465
[TBL] [Abstract][Full Text] [Related]
12. Processing of proinsulin by transfected hepatoma (FAO) cells.
Vollenweider F; Irminger JC; Gross DJ; Villa-Komaroff L; Halban PA
J Biol Chem; 1992 Jul; 267(21):14629-36. PubMed ID: 1634510
[TBL] [Abstract][Full Text] [Related]
13. Differential kinetics of rat insulin I and II processing in rat islets of Langerhans.
Gishizky ML; Grodsky GM
FEBS Lett; 1987 Nov; 223(2):227-31. PubMed ID: 3311812
[TBL] [Abstract][Full Text] [Related]
14. Des-(27-31)C-peptide. A novel secretory product of the rat pancreatic beta cell produced by truncation of proinsulin connecting peptide in secretory granules.
Verchere CB; Paoletta M; Neerman-Arbez M; Rose K; Irminger JC; Gingerich RL; Kahn SE; Halban PA
J Biol Chem; 1996 Nov; 271(44):27475-81. PubMed ID: 8910330
[TBL] [Abstract][Full Text] [Related]
15. Substrate specificity of proinsulin conversion in the constitutive pathway of transfected FAO (hepatoma) cells.
Vollenweider F; Irminger JC; Halban PA
Diabetologia; 1993 Dec; 36(12):1322-5. PubMed ID: 8307263
[TBL] [Abstract][Full Text] [Related]
16. Secretion of insulin in a perifusion system and conversion of proinsulin to insulin by pancreatic islets from hyperglycemic rats.
Jain K; Logothetopoulos J
Diabetes; 1977 Jul; 26(7):650-6. PubMed ID: 326605
[TBL] [Abstract][Full Text] [Related]
17. Familial hyperproinsulinemia. Two cohorts secreting indistinguishable type II intermediates of proinsulin conversion.
Robbins DC; Shoelson SE; Rubenstein AH; Tager HS
J Clin Invest; 1984 Mar; 73(3):714-9. PubMed ID: 6368587
[TBL] [Abstract][Full Text] [Related]
18. In vitro conversion of proinsulin to insulin by cathepsin B and role of C-peptide.
Puri RB; Anjaneyulu K; Kidwai JR; Mohan Rao VK
Acta Diabetol Lat; 1978; 15(5-6):243-50. PubMed ID: 373354
[TBL] [Abstract][Full Text] [Related]
19. Relative hypersecretion of proinsulin in rat model of NIDDM.
Leahy JL; Halban PA; Weir GC
Diabetes; 1991 Aug; 40(8):985-9. PubMed ID: 1860563
[TBL] [Abstract][Full Text] [Related]
20. Preferential cleavage of des-31,32-proinsulin over intact proinsulin by the insulin secretory granule type II endopeptidase. Implication of a favored route for prohormone processing.
Rhodes CJ; Lincoln B; Shoelson SE
J Biol Chem; 1992 Nov; 267(32):22719-27. PubMed ID: 1429623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
